Aethlon Medical Statistics
Share Statistics
Aethlon Medical has 13.96M shares outstanding. The number of shares has increased by 459.08% in one year.
| Shares Outstanding | 13.96M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 0.27% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 13.64M |
| Failed to Deliver (FTD) Shares | 5.53K |
| FTD / Avg. Volume | 0.91% |
Short Selling Information
The latest short interest is 286.15K, so 2.05% of the outstanding shares have been sold short.
| Short Interest | 286.15K |
| Short % of Shares Out | 2.05% |
| Short % of Float | 2.1% |
| Short Ratio (days to cover) | 0.98 |
Valuation Ratios
The PE ratio is -0.36 and the forward PE ratio is -0.6.
| PE Ratio | -0.36 |
| Forward PE | -0.6 |
| PS Ratio | 0 |
| Forward PS | 3.1 |
| PB Ratio | 0.75 |
| P/FCF Ratio | -0.42 |
| PEG Ratio | n/a |
Enterprise Valuation
Aethlon Medical Inc. has an Enterprise Value (EV) of -.
| EV / Earnings | null |
| EV / Sales | null |
| EV / EBITDA | null |
| EV / EBIT | null |
| EV / FCF | null |
Financial Position
The company has a current ratio of 3.25, with a Debt / Equity ratio of 0.
| Current Ratio | 3.25 |
| Quick Ratio | 3.25 |
| Debt / Equity | 0 |
| Total Debt / Capitalization | 0 |
| Cash Flow / Debt | 0 |
| Interest Coverage | 0 |
Financial Efficiency
Return on equity (ROE) is -2.12% and return on capital (ROIC) is -188.42%.
| Return on Equity (ROE) | -2.12% |
| Return on Assets (ROA) | -1.48% |
| Return on Capital (ROIC) | -188.42% |
| Revenue Per Employee | 0 |
| Profits Per Employee | -872.01K |
| Employee Count | 14 |
| Asset Turnover | 0 |
| Inventory Turnover | 0 |
Taxes
| Income Tax | 3 |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -82% in the last 52 weeks. The beta is 1.75, so Aethlon Medical 's price volatility has been higher than the market average.
| Beta | 1.75 |
| 52-Week Price Change | -82% |
| 50-Day Moving Average | 0.39 |
| 200-Day Moving Average | 0.72 |
| Relative Strength Index (RSI) | 40.11 |
| Average Volume (20 Days) | 611.38K |
Income Statement
In the last 12 months, Aethlon Medical had revenue of $0 and earned -$12.21M in profits. Earnings per share was $-4.86.
| Revenue | 0 |
| Gross Profit | -359.06K |
| Operating Income | -12.64M |
| Net Income | -12.21M |
| EBITDA | -11.85M |
| EBIT | - |
| Earnings Per Share (EPS) | -4.86 |
Balance Sheet
The company has $5.44M in cash and $940.32K in debt, giving a net cash position of $4.50M.
| Cash & Cash Equivalents | 5.44M |
| Total Debt | 940.32K |
| Net Cash | 4.50M |
| Retained Earnings | -154.57M |
| Total Assets | 8.85M |
| Working Capital | 7.14B |
Cash Flow
In the last 12 months, operating cash flow was -$10.13M and capital expenditures -$250.87K, giving a free cash flow of -$10.38M.
| Operating Cash Flow | -10.13M |
| Capital Expenditures | -250.87K |
| Free Cash Flow | -10.38M |
| FCF Per Share | -4.13 |
Margins
Gross margin is 0%, with operating and profit margins of 0% and 0%.
| Gross Margin | 0% |
| Operating Margin | 0% |
| Pretax Margin | 0% |
| Profit Margin | 0% |
| EBITDA Margin | n/a% |
| EBIT Margin | n/a% |
| FCF Margin | n/a% |
Dividends & Yields
AEMD does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -1350% |
| FCF Yield | -207.97% |
Analyst Forecast
The average price target for AEMD is $7, which is 1844.4% higher than the current price. The consensus rating is "Buy".
| Price Target | $7 |
| Price Target Difference | 1844.4% |
| Analyst Consensus | Buy |
| Analyst Count | 1 |
Stock Splits
The last stock split was on Oct 5, 2023. It was a backward split with a ratio of 1:10.
| Last Split Date | Oct 5, 2023 |
| Split Type | backward |
| Split Ratio | 1:10 |
Scores
| Altman Z-Score | 938.3 |
| Piotroski F-Score | 2 |